MedX Health and Calian’s Primacy Management Join Together to Provide
On-the-Spot Suspicious Mole and Lesion Scans at the Melanoma Network of
Canada’s “Strides for Melanoma Walk for Awareness” Fundraiser

October 12, 2017 10:46 AM Eastern Daylight Time

MISSISSAUGA, Ontario--(BUSINESS WIRE)--MedX Health Corp. (“MedX”) (TSX-V: MDX) notes that despite unusually
sweltering heat in Toronto, hundreds of people participated in the
Strides for Melanoma Walk for Awareness on Sunday, September 24 in
Sunnybrook Park. The annual event, which included concurrent 5Km walks
in cities across Canada, is a key fundraiser organized by the Melanoma
Network of Canada (“MNC”), a national skin cancer patient advocacy and
educational network.

The MNC is collaborating with MedX to create an early detection and sun
safety program for Canadians through participating corporations across
the country, including melanoma and sun safety education, and an onsite
skin cancer-screening program using MedX’s
pain-free, non-invasive SIAscopy technology.

MedX and Primacy set up a booth at the MNC’s Strides Walk in Toronto so
that participants, many of whom have lost loved ones to melanoma, could
have their moles or lesions scanned on the spot.

“We took almost 90 scans within a few hours and identified a number of
suspicious moles and lesions for follow-up,” said Mike Druhan, Vice
President, Corporate Development at MedX. “One of the most compelling
and meaningful aspects of MedX’s pain-free, non-invasive scanning
technology is that we can quickly alleviate the anxiety of not knowing
whether a mole or lesion could be cancer. A scan takes mere seconds and
there is no discomfort to the individual. When reviewed by a trained
professional, our technology can discern very quickly and accurately if
a mole or lesion is suspicious,” Mr. Druhan said.

Dr. Paul Cohen, a renowned Toronto-based dermatologist who is also on
MedX’s Medical Advisory Board, assisted at the Strides Walk by offering
on-site review of the scans. Most of the scans were found to be benign,
and any of those that were suspicious are being followed up by Dr. Cohen.

“The value of MedX’s innovative technology is undeniable – it helps save
lives. Skin cancer rates are rising expeditiously around the world, and
in some areas of the globe are bordering on epidemic levels. If the
medical community had access to MedX’s SIAscopy technology, it would be
a game-changer, potentially saving many millions of lives,” Dr. Cohen
said.

Primacy General Manager, Melanie Holek, said: “This technology is being
very well received by patients and our goal is to expand this program
across Canada.” Primacy’s pilot program with MedX's screening solution
is going well in select Primacy clinics. Current locations include
Hamilton, Carleton Place, Ont., and Sudbury, with a Toronto location
expected soon.

“Incidence rates of melanoma have increased in both males and females
over the past several decades. With the rising number of new cases each
year amongst Canadians, there will be a corresponding increase in the
need for easy access to screening, detection and treatment,” said Alexa
Cain, Executive Director of MNC. “MedX and Primacy are working together
to revolutionize the healthcare system and save more Canadian lives
through early detection.”

According to the Skin Cancer Foundation of Canada, approximately 80,000
skin cancers are diagnosed in the country each year, more than 5,000 of
which are melanoma, the deadliest form of skin cancer. There are more
new cases of skin cancer annually than those of breast, prostate, lung
and colon cancers combined. Despite this, only about 10% of Canadians
have their moles and lesions screened on a regular basis.

Melanoma is the deadliest form of skin cancer and is one of the most
commonly diagnosed cancers in young people aged 15 to 29. When caught
early it is largely curable, but once the cancer has spread to other
organs the median life expectancy is less than a year and costs the
healthcare system exponentially more due to a need for very expensive
treatments. Frequent skin screenings, early detection and a strong focus
on prevention are all necessary to stop the rise in melanoma cases.

About MedXMedX, headquartered in Mississauga, Ontario, is a
leading medical device company focused on skin cancer with its SIAscopy
technology. This technology is imbedded in its products SIAMETRICS™,
SIMSYS™, and MoleMate™, which MedX manufactures in its ISO 13485
certified facility. SIAMETRICS™, SIMSYS™, and MoleMate™ include
hand-held devices that use patented technology utilizing light and its
remittance to view up to 2 mm beneath suspicious moles and lesions in a
pain free, non-invasive manner, with its software then creating
real-time images for physicians and dermatologists to evaluate all types
of moles or lesions within seconds. The devices are sold to physicians
and clinics, as well as being deployed in pharmacies and remote clinics
from where the images are sent to dermatologists who perform a
diagnosis. These products are Health Canada, FDA (US), ARTG and CE
approved for use in Canada, the US, Australia, the European Union and
Turkey. SIAMETRICS™ is a unique product used in a specialized market for
research into the clinical effectiveness of medical treatments of
certain skin conditions. MedX also designs, manufactures and distributes
quality laser and light therapy technologies for use in numerous medical
settings, approved in major jurisdictions, to provide drug free and
non-invasive treatment of tissue damage and pain. For more information
and a complete profile of MedX and its products visit www.medxhealth.com.

About the Melanoma Network of CanadaThe Melanoma Network of
Canada (MNC) provides support services, information and programs for
individuals whose lives have been changed by melanoma. MNC provides the
leading national voice for melanoma patients in Canada for early
detection and improved treatment access and works diligently to prevent
more Canadians from developing melanoma through public awareness and
youth and adult education on sun safety. For more information, please
visit www.melanomanetwork.ca.
Charitable Registration number: 854913050RR0001

About Primacy Management Inc., a Calian Group CompanyPrimacy
is the largest medical clinic management company in Canada with more
than 800 physicians practicing at more than 140 clinics located in
Loblaw stores (including Real Canadian Superstore®, Zehrs®,
Loblaws® and No Frills®) across Canada.
Primacy clinics collectively serve over 6 million patients a year. http://www.primacyclinics.ca/

About Calian HealthCalian Health is one of Canada's largest
national health services organizations with over 10 years of experience
in the management of healthcare professionals and health programs, as
well as the operation and management of primary care and occupational
health. With a network of over 1,800 healthcare professionals, Calian
supports over six million patient visits per year at over 180 clinic
locations across Canada. https://www.calian.com/en/services/health-
clinics services